日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial

按需使用布地奈德-福莫特罗治疗轻度哮喘成人患者的成本效益分析:Novel START试验

Leung, William; Reddel, Helen K; Hung, Tiffany; Weatherall, Mark; Pelzer, Ilka; Holliday, Mark; Sullivan, Trudy; Harrison, Tim; Pavord, Ian D; Baker, Michael G; Ebmeier, Stefan; Papi, Alberto; Beasley, Richard; Hancox, Robert J

Evaluating Asthma Clinical Remission with Inhaled Therapy: Post Hoc Analyses of CAPTAIN

评估吸入疗法对哮喘临床缓解的影响:CAPTAIN 研究的事后分析

Oppenheimer, John; Pavord, Ian D; Corbridge, Tom; Crawford, Jodie; Gould, Steven; Hamouda, Mohamed; Howarth, Peter; Burrows, Emmeline; Moore, Alison; Noorduyn, Stephen G; Slade, David; Weng, Stephen; Lugogo, Njira

Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review

哮喘患者吸入性皮质类固醇和支气管扩张剂治疗反应预测特征的误区:一项叙述性综述

Brusselle, Guy; Crawford, Jodie; Gibson, Peter G; Leather, David; Moore, Alison; Oppenheimer, John J; Pavord, Ian D; Stanaland, Marcus; Pizzichini, Emilio

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials

哮喘发作的炎症和临床危险因素(ORACLE2):一项包含22项随机试验对照组的患者水平荟萃分析

Meulmeester, Fleur L; Mailhot-Larouche, Samuel; Celis-Preciado, Carlos; Lemaire-Paquette, Samuel; Ramakrishnan, Sanjay; Wechsler, Michael E; Brusselle, Guy; Corren, Jonathan; Hardy, Jo; Diver, Sarah E; Brightling, Christopher E; Castro, Mario; Hanania, Nicola A; Jackson, David J; Martin, Neil; Laugerud, Annette; Santoro, Emilio; Compton, Chris; Hardin, Megan E; Holweg, Cecile T J; Subhashini, Allu; Hinks, Timothy S C; Beasley, Richard W; Sont, Jacob K; Steyerberg, Ewout W; Pavord, Ian D; Couillard, Simon

Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study

接受抗IL-5/5Rα治疗的患者呼出气一氧化氮分数与泼尼松龙治疗哮喘发作的反应:一项前瞻性观察研究

Howell, Imran; Mahdi, Mahdi; Mahmood, Hafiz R; Bermejo-Sanchez, Laura; Borg, Catherine; Ramakrishnan, Sanjay; Melhorn, James; Lavoie, Gabriel; Petousi, Nayia; Hinks, Timothy S C; Bafadhel, Mona; Pavord, Ian D

Normal FEV(1) without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis

哮喘试验中正常FEV1无可逆性:安慰剂患者水平荟萃分析

Couillard, Simon; Mailhot-Larouche, Samuel; Meulmeester, Fleur L; Brusselle, Guy; Lachapelle, Philippe; Beasley, Richard W; Sont, Jacob K; Steyerberg, Ewout W; Pavord, Ian D; Lugogo, Njira

Stop the Asthma Treatment Elevator, We Need to Get Off!

停止哮喘治疗电梯,我们需要下车!

Bush, Andrew; Pavord, Ian D

Choosing the Right Biologic for the Right Patient With Severe Asthma

为重度哮喘患者选择合适的生物制剂

Couillard, Simon; Jackson, David J; Pavord, Ian D; Wechsler, Michael E

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment

阿奇霉素对伴有单克隆抗体治疗的重度嗜酸性粒细胞性哮喘的影响

Lavoie, Gabriel; Howell, Imran; Melhorn, James; Borg, Catherine; Bermejo-Sanchez, Laura; Seymour, Jack; Jabeen, Maisha F; Fries, Anastasia; Hynes, Gareth; Pavord, Ian D; Petousi, Nayia; Hinks, Timothy Sc

The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New Zealand

口服皮质类固醇治疗哮喘发作的风险收益平衡:英国和新西兰患者及医护人员的离散选择实验

Howell, Imran; Noble, Jonathan; Howell, Aleksandra; Morgan, Caitlin; Logan, Jennifer; Miller, Sarah; Chaudhuri, Rekha; Russell, Richard E K; Bafadhel, Mona; Beasley, Richard; Pavord, Ian D; Buckell, John